| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 3.90e-05 | 11 | 126 | 3 | GO:0015165 | |
| GeneOntologyMolecularFunction | UDP-glucuronic acid transmembrane transporter activity | 3.95e-05 | 2 | 126 | 2 | GO:0005461 | |
| GeneOntologyMolecularFunction | UDP-N-acetylgalactosamine transmembrane transporter activity | 3.95e-05 | 2 | 126 | 2 | GO:0005463 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 8.49e-05 | 14 | 126 | 3 | GO:0005338 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 8.50e-05 | 37 | 126 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 9.45e-05 | 38 | 126 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | UDP-glucose transmembrane transporter activity | 1.18e-04 | 3 | 126 | 2 | GO:0005460 | |
| GeneOntologyMolecularFunction | UDP-N-acetylglucosamine transmembrane transporter activity | 3.90e-04 | 5 | 126 | 2 | GO:0005462 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 5.26e-04 | 59 | 126 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 5.26e-04 | 59 | 126 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | interleukin-1 receptor activity | 1.08e-03 | 8 | 126 | 2 | GO:0004908 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 1.37e-03 | 76 | 126 | 4 | GO:0098631 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 1.38e-03 | 9 | 126 | 2 | GO:0017151 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.64e-03 | 430 | 126 | 9 | GO:0004175 | |
| GeneOntologyBiologicalProcess | UDP-N-acetylgalactosamine transmembrane transport | 3.64e-05 | 2 | 125 | 2 | GO:0015789 | |
| GeneOntologyBiologicalProcess | UDP-glucuronic acid transmembrane transport | 3.64e-05 | 2 | 125 | 2 | GO:0015787 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide-sugar transmembrane transport | 4.59e-05 | 12 | 125 | 3 | GO:0090481 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar transmembrane transport | 5.94e-05 | 13 | 125 | 3 | GO:0015780 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 7.53e-06 | 7 | 127 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 3.49e-05 | 11 | 127 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | growth cone | 1.28e-04 | 245 | 127 | 8 | GO:0030426 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PCSK1 PCSK5 MAPK8IP1 ARHGAP32 HTR1D MAP1B ANKS1B NCAM1 ALS2 GDPD5 DIP2A NELL2 SHANK2 SACS KDR LYNX1 GRIN3B USH2A IL6ST | 1.55e-04 | 1228 | 127 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | site of polarized growth | 1.60e-04 | 253 | 127 | 8 | GO:0030427 | |
| GeneOntologyCellularComponent | distal axon | PCSK1 MAPK8IP1 MAP1B NCAM1 ALS2 TSC1 GDPD5 SHANK2 USH2A CXADR | 3.29e-04 | 435 | 127 | 10 | GO:0150034 |
| GeneOntologyCellularComponent | cell body | PCSK1 PCSK5 MAPK8IP1 MAP1B NCAM1 ALS2 GDPD5 NELL2 SHANK2 KDR GRIN3B USH2A WNK4 IL6ST CXADR | 5.22e-04 | 929 | 127 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | dendrite | PCSK1 PCSK5 MAPK8IP1 ARHGAP32 HTR1D MAP1B ANKS1B ALS2 DIP2A NELL2 SHANK2 SACS LYNX1 IL6ST | 7.29e-04 | 858 | 127 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | PCSK1 PCSK5 MAPK8IP1 ARHGAP32 HTR1D MAP1B ANKS1B ALS2 DIP2A NELL2 SHANK2 SACS LYNX1 IL6ST | 7.45e-04 | 860 | 127 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | hippocampal mossy fiber | 7.54e-04 | 7 | 127 | 2 | GO:0097457 | |
| GeneOntologyCellularComponent | side of membrane | NTNG1 NCAM1 CR2 CNTN6 SCUBE1 THADA ANTXR2 SMPDL3B KDR LYNX1 FCRL5 ATP2A2 KLRB1 IL6ST | 8.81e-04 | 875 | 127 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | axon | PCSK1 MAPK8IP1 MAP1B MYOC NCAM1 ALS2 TSC1 CNTN6 GDPD5 SHANK2 SACS USH2A ADGRL3 CXADR | 1.05e-03 | 891 | 127 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | neuronal cell body | PCSK1 PCSK5 MAPK8IP1 MAP1B NCAM1 ALS2 GDPD5 NELL2 SHANK2 KDR GRIN3B USH2A IL6ST | 1.72e-03 | 835 | 127 | 13 | GO:0043025 |
| Domain | Ig-like_fold | FNDC3B SEMA3C VSIG2 FSTL4 NCAM1 IL18RAP CNTN6 FNDC7 CD7 SHANK2 IL1R2 SIGIRR KDR ADGRF5 FCRL5 USH2A SDK1 GPA33 IL6ST CXADR | 2.65e-08 | 706 | 121 | 20 | IPR013783 |
| Domain | - | FNDC3B SEMA3C VSIG2 FSTL4 NCAM1 IL18RAP CNTN6 FNDC7 CD7 IL1R2 SIGIRR KDR ADGRF5 FCRL5 USH2A SDK1 GPA33 IL6ST CXADR | 5.15e-08 | 663 | 121 | 19 | 2.60.40.10 |
| Domain | IGc2 | VSIG2 FSTL4 NCAM1 CNTN6 IL1R2 KDR ADGRF5 FCRL5 SDK1 GPA33 CXADR | 3.75e-07 | 235 | 121 | 11 | SM00408 |
| Domain | Ig_sub2 | VSIG2 FSTL4 NCAM1 CNTN6 IL1R2 KDR ADGRF5 FCRL5 SDK1 GPA33 CXADR | 3.75e-07 | 235 | 121 | 11 | IPR003598 |
| Domain | IG | SEMA3C VSIG2 FSTL4 NCAM1 IL18RAP CNTN6 CD7 IL1R2 KDR ADGRF5 FCRL5 SDK1 GPA33 CXADR | 5.96e-07 | 421 | 121 | 14 | SM00409 |
| Domain | Ig_sub | SEMA3C VSIG2 FSTL4 NCAM1 IL18RAP CNTN6 CD7 IL1R2 KDR ADGRF5 FCRL5 SDK1 GPA33 CXADR | 5.96e-07 | 421 | 121 | 14 | IPR003599 |
| Domain | IG_LIKE | SEMA3C VSIG2 FSTL4 NCAM1 IL18RAP CNTN6 CD7 IL1R2 SIGIRR KDR ADGRF5 FCRL5 SDK1 GPA33 CXADR | 6.71e-07 | 491 | 121 | 15 | PS50835 |
| Domain | Ig-like_dom | SEMA3C VSIG2 FSTL4 NCAM1 IL18RAP CNTN6 CD7 IL1R2 SIGIRR KDR ADGRF5 FCRL5 SDK1 GPA33 CXADR | 9.08e-07 | 503 | 121 | 15 | IPR007110 |
| Domain | EGF | PCSK5 FRAS1 NTNG1 LAMC1 ADAM32 SVEP1 NELL2 SCUBE1 CNTNAP5 PCSK6 | 3.07e-06 | 235 | 121 | 10 | SM00181 |
| Domain | Ig_I-set | 4.09e-06 | 190 | 121 | 9 | IPR013098 | |
| Domain | I-set | 4.09e-06 | 190 | 121 | 9 | PF07679 | |
| Domain | EGF-like_dom | PCSK5 FRAS1 NTNG1 LAMC1 ADAM32 SVEP1 NELL2 SCUBE1 CNTNAP5 PCSK6 | 5.13e-06 | 249 | 121 | 10 | IPR000742 |
| Domain | Peptidase_S8_Asp-AS | 5.23e-06 | 6 | 121 | 3 | IPR023827 | |
| Domain | - | 7.80e-06 | 73 | 121 | 6 | 2.60.120.260 | |
| Domain | P_proprotein | 9.11e-06 | 7 | 121 | 3 | PF01483 | |
| Domain | S8_pro-domain | 9.11e-06 | 7 | 121 | 3 | IPR032815 | |
| Domain | PrprotnconvertsP | 9.11e-06 | 7 | 121 | 3 | IPR002884 | |
| Domain | Aspartic_peptidase_N | 9.11e-06 | 7 | 121 | 3 | IPR012848 | |
| Domain | - | 9.11e-06 | 7 | 121 | 3 | 3.30.70.850 | |
| Domain | S8_pro-domain | 9.11e-06 | 7 | 121 | 3 | PF16470 | |
| Domain | A1_Propeptide | 9.11e-06 | 7 | 121 | 3 | PF07966 | |
| Domain | Peptidase_S8_His-AS | 2.17e-05 | 9 | 121 | 3 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 2.17e-05 | 9 | 121 | 3 | IPR023828 | |
| Domain | Aspartic_peptidase_A1 | 3.08e-05 | 10 | 121 | 3 | IPR001461 | |
| Domain | Sugar_P_trans_dom | 3.08e-05 | 10 | 121 | 3 | IPR004853 | |
| Domain | Peptidase_S8_subtilisin-rel | 3.08e-05 | 10 | 121 | 3 | IPR015500 | |
| Domain | PEPTIDASE_A1 | 3.08e-05 | 10 | 121 | 3 | IPR033121 | |
| Domain | Asp | 3.08e-05 | 10 | 121 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 3.08e-05 | 10 | 121 | 3 | PS51767 | |
| Domain | SUBTILASE_ASP | 3.08e-05 | 10 | 121 | 3 | PS00136 | |
| Domain | SUBTILASE_HIS | 3.08e-05 | 10 | 121 | 3 | PS00137 | |
| Domain | SUBTILASE_SER | 3.08e-05 | 10 | 121 | 3 | PS00138 | |
| Domain | TPT | 3.08e-05 | 10 | 121 | 3 | PF03151 | |
| Domain | Galactose-bd-like | 3.34e-05 | 94 | 121 | 6 | IPR008979 | |
| Domain | ig | 3.34e-05 | 190 | 121 | 8 | PF00047 | |
| Domain | Immunoglobulin | 3.34e-05 | 190 | 121 | 8 | IPR013151 | |
| Domain | IL-1_rcpt_fam | 4.21e-05 | 11 | 121 | 3 | IPR015621 | |
| Domain | - | 4.21e-05 | 11 | 121 | 3 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 4.21e-05 | 11 | 121 | 3 | IPR000209 | |
| Domain | Peptidase_S8 | 4.21e-05 | 11 | 121 | 3 | PF00082 | |
| Domain | - | 5.59e-05 | 12 | 121 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 5.59e-05 | 12 | 121 | 3 | PS00141 | |
| Domain | Growth_fac_rcpt_ | 7.06e-05 | 156 | 121 | 7 | IPR009030 | |
| Domain | Aspartic_peptidase_AS | 7.23e-05 | 13 | 121 | 3 | IPR001969 | |
| Domain | fn3 | 8.95e-05 | 162 | 121 | 7 | PF00041 | |
| Domain | Laminin_N | 1.40e-04 | 16 | 121 | 3 | IPR008211 | |
| Domain | LamNT | 1.40e-04 | 16 | 121 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 1.40e-04 | 16 | 121 | 3 | PS51117 | |
| Domain | Laminin_N | 1.40e-04 | 16 | 121 | 3 | PF00055 | |
| Domain | Propept_inh | 1.69e-04 | 17 | 121 | 3 | IPR009020 | |
| Domain | Peptidase_aspartic_dom | 1.69e-04 | 17 | 121 | 3 | IPR021109 | |
| Domain | Furin_repeat | 2.02e-04 | 18 | 121 | 3 | IPR006212 | |
| Domain | FU | 2.02e-04 | 18 | 121 | 3 | SM00261 | |
| Domain | FN3 | 2.04e-04 | 185 | 121 | 7 | SM00060 | |
| Domain | EGF_1 | 2.58e-04 | 255 | 121 | 8 | PS00022 | |
| Domain | FN3 | 3.18e-04 | 199 | 121 | 7 | PS50853 | |
| Domain | FN3_dom | 4.27e-04 | 209 | 121 | 7 | IPR003961 | |
| Domain | Ephrin_rec_like | 5.50e-04 | 25 | 121 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 5.50e-04 | 25 | 121 | 3 | IPR011641 | |
| Domain | GF_recep_IV | 6.14e-04 | 6 | 121 | 2 | PF14843 | |
| Domain | GF_recep_IV | 6.14e-04 | 6 | 121 | 2 | IPR032778 | |
| Domain | EGF_LAM_2 | 9.48e-04 | 30 | 121 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 9.48e-04 | 30 | 121 | 3 | PS01248 | |
| Domain | IGv | 1.43e-03 | 75 | 121 | 4 | SM00406 | |
| Domain | EGF_Lam | 1.49e-03 | 35 | 121 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.49e-03 | 35 | 121 | 3 | PF00053 | |
| Domain | EGF_2 | 1.71e-03 | 265 | 121 | 7 | PS01186 | |
| Domain | VPS9 | 1.81e-03 | 10 | 121 | 2 | PS51205 | |
| Domain | VPS9 | 1.81e-03 | 10 | 121 | 2 | PF02204 | |
| Domain | VPS9 | 1.81e-03 | 10 | 121 | 2 | IPR003123 | |
| Domain | Laminin_EGF | 1.90e-03 | 38 | 121 | 3 | IPR002049 | |
| Domain | Laminin_G_2 | 2.20e-03 | 40 | 121 | 3 | PF02210 | |
| Domain | Ephrin_rec_like | 2.20e-03 | 11 | 121 | 2 | PF07699 | |
| Domain | LamG | 2.89e-03 | 44 | 121 | 3 | SM00282 | |
| Domain | OLF | 3.10e-03 | 13 | 121 | 2 | PF02191 | |
| Domain | OLF | 3.10e-03 | 13 | 121 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 3.10e-03 | 13 | 121 | 2 | IPR003112 | |
| Domain | OLF | 3.10e-03 | 13 | 121 | 2 | SM00284 | |
| Domain | - | 3.39e-03 | 95 | 121 | 4 | 2.60.120.200 | |
| Domain | PLAC | 3.60e-03 | 14 | 121 | 2 | PF08686 | |
| Domain | - | 4.14e-03 | 15 | 121 | 2 | 3.30.70.960 | |
| Domain | EGF_3 | 4.30e-03 | 235 | 121 | 6 | PS50026 | |
| Domain | VWA | 5.73e-03 | 56 | 121 | 3 | PF00092 | |
| Domain | Laminin_G | 6.32e-03 | 58 | 121 | 3 | IPR001791 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 3.13e-05 | 30 | 86 | 4 | M27566 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 3.49e-05 | 11 | 86 | 3 | M39726 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.10e-04 | 41 | 86 | 4 | MM15075 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.33e-04 | 43 | 86 | 4 | M881 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 7926498 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 9561228 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 21455714 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 19800305 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 4.76e-08 | 3 | 127 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 4.76e-08 | 3 | 127 | 3 | 2799289 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 4.76e-08 | 3 | 127 | 3 | 1968039 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 8053437 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 4.76e-08 | 3 | 127 | 3 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 4.76e-08 | 3 | 127 | 3 | 2229438 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 4.76e-08 | 3 | 127 | 3 | 19890696 | |
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 4.76e-08 | 3 | 127 | 3 | 8244094 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 21407214 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 6774973 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 4.76e-08 | 3 | 127 | 3 | 22304859 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 24004680 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 4.76e-08 | 3 | 127 | 3 | 2227273 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 23034090 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 24125879 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 4.76e-08 | 3 | 127 | 3 | 3554488 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 23521833 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 4.76e-08 | 3 | 127 | 3 | 21989121 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 9855083 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 9797498 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 2478370 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 4.76e-08 | 3 | 127 | 3 | 10675278 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 3780036 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 4.76e-08 | 3 | 127 | 3 | 3839486 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 3467902 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 4.76e-08 | 3 | 127 | 3 | 2892778 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 24383519 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 4.76e-08 | 3 | 127 | 3 | 2831884 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 2032552 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 1812762 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 7923573 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 4.76e-08 | 3 | 127 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 4.76e-08 | 3 | 127 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 4.76e-08 | 3 | 127 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 4.76e-08 | 3 | 127 | 3 | 1956484 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 8540382 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 4.76e-08 | 3 | 127 | 3 | 20981206 | |
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 4.76e-08 | 3 | 127 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 4.76e-08 | 3 | 127 | 3 | 21970995 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 20428942 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 9525001 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 7886402 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 17379991 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 21547904 | ||
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 1.90e-07 | 4 | 127 | 3 | 23047493 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 1.90e-07 | 4 | 127 | 3 | 11915945 | |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 8322031 | ||
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 1.90e-07 | 4 | 127 | 3 | 17136346 | |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 12698190 | ||
| Pubmed | Processing of prothyrotropin-releasing hormone by the family of prohormone convertases. | 4.73e-07 | 5 | 127 | 3 | 9242664 | |
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 22066020 | ||
| Pubmed | 6.30e-07 | 19 | 127 | 4 | 23149075 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 8940009 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 9291583 | ||
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 10409610 | ||
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 7819324 | ||
| Pubmed | Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. | 2.63e-06 | 8 | 127 | 3 | 9885250 | |
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 10037747 | ||
| Pubmed | The activation and physiological functions of the proprotein convertases. | 3.93e-06 | 9 | 127 | 3 | 18343183 | |
| Pubmed | The biology and therapeutic targeting of the proprotein convertases. | 3.93e-06 | 9 | 127 | 3 | 22679642 | |
| Pubmed | The prohormone theory and the proprotein convertases: it is all about serendipity. | 3.93e-06 | 9 | 127 | 3 | 21805236 | |
| Pubmed | 3.93e-06 | 9 | 127 | 3 | 21805237 | ||
| Pubmed | 3.93e-06 | 9 | 127 | 3 | 23775089 | ||
| Pubmed | 3.93e-06 | 9 | 127 | 3 | 8698813 | ||
| Pubmed | 5.60e-06 | 10 | 127 | 3 | 16163737 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 2714789 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 3197840 | ||
| Pubmed | Crystal structure of human pepsin and its complex with pepstatin. | 1.32e-05 | 2 | 127 | 2 | 7663352 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 18061232 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 20652271 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8335106 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8468318 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 2415509 | ||
| Pubmed | DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing. | 1.32e-05 | 2 | 127 | 2 | 18195017 | |
| Pubmed | A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. | 1.32e-05 | 13 | 127 | 3 | 21079607 | |
| Pubmed | Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst. | 2.57e-05 | 16 | 127 | 3 | 20876279 | |
| Pubmed | PCSK5 FNDC3B SEMA3C FRAS1 PDE3B ATRX MAP1B EWSR1 AKAP8L DIP2A ZC3HAV1 | 2.80e-05 | 650 | 127 | 11 | 38777146 | |
| Pubmed | 3.02e-05 | 162 | 127 | 6 | 25826454 | ||
| Pubmed | 3.73e-05 | 18 | 127 | 3 | 36057966 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 27601211 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 21041274 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 21935948 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 8670066 | ||
| GeneFamily | Immunoglobulin like domain containing | FSTL4 IL18RAP IL1R2 SIGIRR KDR ADGRF5 FCRL5 SDK1 GPA33 CXADR | 3.34e-08 | 193 | 88 | 10 | 594 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.17e-06 | 161 | 88 | 8 | 593 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 9.16e-06 | 9 | 88 | 3 | 973 | |
| GeneFamily | Fibronectin type III domain containing | 1.30e-05 | 160 | 88 | 7 | 555 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.14e-05 | 394 | 88 | 10 | 471 | |
| GeneFamily | Solute carriers | SLC35D2 SLC35D1 SLCO4C1 SLC35D3 SLC25A44 SLC5A8 SLC29A4 SLC44A3 | 6.78e-04 | 395 | 88 | 8 | 752 |
| GeneFamily | VPS9 domain containing | 1.03e-03 | 10 | 88 | 2 | 928 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 1.12e-03 | 42 | 88 | 3 | 602 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.20e-03 | 163 | 88 | 5 | 590 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 2.36e-03 | 15 | 88 | 2 | 1296 | |
| GeneFamily | NLR family | 6.53e-03 | 25 | 88 | 2 | 666 | |
| GeneFamily | Ankyrin repeat domain containing | 6.56e-03 | 242 | 88 | 5 | 403 | |
| Coexpression | HAHTOLA_SEZARY_SYNDROM_DN | 2.05e-06 | 43 | 127 | 5 | M18968 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.31e-06 | 196 | 127 | 8 | M3008 | |
| Coexpression | GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP | 5.94e-06 | 199 | 127 | 8 | M4427 | |
| Coexpression | DESCARTES_FETAL_HEART_LYMPHOID_CELLS | 1.90e-05 | 113 | 127 | 6 | M40195 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | SEMA3C FRAS1 WIPI1 RUBCNL SGK3 DIP2A NELL2 DENND1B SHANK2 PCSK6 KDR VAV3 MPPED2 SDK1 | 2.87e-05 | 786 | 127 | 14 | M10961 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.18e-05 | 191 | 127 | 7 | MM17059 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 5.08e-05 | 197 | 127 | 7 | M8271 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN | 5.25e-05 | 198 | 127 | 7 | M6068 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN | 5.42e-05 | 199 | 127 | 7 | M6066 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN | 5.59e-05 | 200 | 127 | 7 | M8001 | |
| Coexpression | NABA_CORE_MATRISOME | 6.05e-05 | 275 | 127 | 8 | M5884 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.11e-09 | 195 | 127 | 9 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 8.59e-08 | 193 | 127 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 9.30e-08 | 195 | 127 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.30e-08 | 195 | 127 | 8 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-08 | 196 | 127 | 8 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.05e-07 | 198 | 127 | 8 | 1851b7f4198b42c21c934e2fbda39dbd65e2625c | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.28e-07 | 162 | 127 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.05e-07 | 166 | 127 | 7 | a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.05e-07 | 166 | 127 | 7 | c64971c27cb445dffc5a636d4b6a60261b93a2db | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.05e-07 | 166 | 127 | 7 | 2f3072a7af048f184d33065fdd36153fd563155a | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.05e-07 | 166 | 127 | 7 | 188f2575511f418216874aed9118aa6f165252cb | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.93e-07 | 174 | 127 | 7 | 33d6b81f31bfcb9c4b30206d88e20b9a94fba4a2 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-07 | 180 | 127 | 7 | 3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-07 | 180 | 127 | 7 | 47e345359064dc8ceec982b062e47802e728b43f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-07 | 182 | 127 | 7 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | IPF-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 9.37e-07 | 182 | 127 | 7 | f91bb45baaec76cb3bb26eedbcf0709b2492e93f | |
| ToppCell | IPF-Lymphoid-ILC_A|IPF / Disease state, Lineage and Cell class | 9.72e-07 | 183 | 127 | 7 | 49bfeaae13eb236f61a5486ee75c39789936bb8a | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-06 | 185 | 127 | 7 | 3b2da51aec057b462749ae39afb8f253afcf38d5 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.12e-06 | 187 | 127 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-06 | 188 | 127 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.25e-06 | 190 | 127 | 7 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.29e-06 | 191 | 127 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.29e-06 | 191 | 127 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-06 | 192 | 127 | 7 | 7197e401e563441ab94815f7619e032ebef9e586 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.34e-06 | 192 | 127 | 7 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.44e-06 | 194 | 127 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 194 | 127 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.49e-06 | 195 | 127 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 1.54e-06 | 196 | 127 | 7 | f7e5a7fad4547e8ab9ab8b140239281832fb4260 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.59e-06 | 197 | 127 | 7 | 550cce374332c49893bcf4ce4b7dceb7f5fe26aa | |
| ToppCell | mLN-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 1.59e-06 | 197 | 127 | 7 | bd1d01d6c49f68f5c85d84df96c90dd04b9de09b | |
| ToppCell | (0)_NK_FCGR3Apos|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.64e-06 | 198 | 127 | 7 | 13f10f9233fc1523f0da2d9d59f3ced9c51a603a | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.64e-06 | 198 | 127 | 7 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 198 | 127 | 7 | c477405b093f4e5374e57bcacf1fb204a0f7eb3b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.64e-06 | 198 | 127 | 7 | 5607e36f393cb399fcc2504502498453fd32d96b | |
| ToppCell | Caecum-T_cell-Treg|Caecum / Region, Cell class and subclass | 1.70e-06 | 199 | 127 | 7 | ab0b32c077ac26d32a293dcf686af6984980793f | |
| ToppCell | Caecum-(1)_T_cell-(15)_Treg|Caecum / shred on region, Cell_type, and subtype | 1.70e-06 | 199 | 127 | 7 | 12c22b07a231c9dc548e9dc37e0a60296a4a6273 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.70e-06 | 199 | 127 | 7 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | severe-NK_CD56bright|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.76e-06 | 200 | 127 | 7 | 82818ab1796fdd0b8be02b341818897595eed841 | |
| ToppCell | URO-Lymphocyte-T_NK-NK_CD56bright|URO / Disease, Lineage and Cell Type | 4.10e-06 | 147 | 127 | 6 | a6ca90e8dc37a016572ff68f34ab227b020eef70 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 5.36e-06 | 154 | 127 | 6 | 51ffb3fa0250bd31be764ed048728aa064056e16 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.44e-06 | 159 | 127 | 6 | a8fa49dc2e6ad726d1f4f2b30693fecd1151a485 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.44e-06 | 159 | 127 | 6 | 95834b767cfb4fb8c5aeea89c10f3e14a1fd15c1 | |
| ToppCell | control-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.67e-06 | 160 | 127 | 6 | f49c810072604c4dee51025073c9e088c00daf4a | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.92e-06 | 161 | 127 | 6 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.17e-06 | 162 | 127 | 6 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.17e-06 | 162 | 127 | 6 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.17e-06 | 162 | 127 | 6 | b115b5799137122bd60696f8ae2aebadad6cd044 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 8.24e-06 | 166 | 127 | 6 | ba42349a68b22e91a0340bda1ccecd6c7592392f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.82e-06 | 168 | 127 | 6 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.82e-06 | 168 | 127 | 6 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-06 | 169 | 127 | 6 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.01e-05 | 172 | 127 | 6 | 68fd03f2c8ee01fe46194400f74ede3830e00f34 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-05 | 172 | 127 | 6 | a126dacd94939851de1403d30f0b63eaad48bfa1 | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.11e-05 | 175 | 127 | 6 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 176 | 127 | 6 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 176 | 127 | 6 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-05 | 176 | 127 | 6 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-05 | 177 | 127 | 6 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 177 | 127 | 6 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 177 | 127 | 6 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | Healthy_Control-Lymphoid-NK-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.23e-05 | 178 | 127 | 6 | 71e99f143009b2d29cb47b96393b58b514c8cfc6 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 178 | 127 | 6 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 179 | 127 | 6 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 180 | 127 | 6 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 180 | 127 | 6 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 182 | 127 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-05 | 184 | 127 | 6 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 185 | 127 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.53e-05 | 185 | 127 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.53e-05 | 185 | 127 | 6 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | COVID-19_Moderate-NK_activated|World / disease group, cell group and cell class | 1.57e-05 | 186 | 127 | 6 | ff8f32f69516bf785224fa12f8139a95359b0279 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-lymphatic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 186 | 127 | 6 | 86b218a400f9c64f92b050f00b49f09647b17437 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 186 | 127 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 186 | 127 | 6 | 5d94e6dd2c92e0c46badeb1e6eb54b69af855a66 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 186 | 127 | 6 | f51c76b1c3c6c49e0ebc9a913d8413e0b6a04d80 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 186 | 127 | 6 | 1da52e13096dfe4eb08bd0e7461cb3809b3b3deb | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.62e-05 | 187 | 127 | 6 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | P03-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.62e-05 | 187 | 127 | 6 | 55618ceec367c1c51ed5c447063d7fbd5c7e0808 | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 1.67e-05 | 188 | 127 | 6 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-05 | 189 | 127 | 6 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | EC-Sinusoidal_ECs|World / Lineage and Cell class | 1.72e-05 | 189 | 127 | 6 | 9a0956c8a7069ba3bd0fa56d052d6e514453e578 | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.72e-05 | 189 | 127 | 6 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-05 | 189 | 127 | 6 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 1.72e-05 | 189 | 127 | 6 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-05 | 189 | 127 | 6 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | Control-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.72e-05 | 189 | 127 | 6 | 89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-05 | 189 | 127 | 6 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-05 | 189 | 127 | 6 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 1.72e-05 | 189 | 127 | 6 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-05 | 190 | 127 | 6 | 92fdfed12061ee9f6c7171cf8a7f3344921f2d40 | |
| ToppCell | P03-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.77e-05 | 190 | 127 | 6 | 347c7bf67ade235a4e2320db6a75ce0dab8744f9 | |
| ToppCell | Control-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 1.77e-05 | 190 | 127 | 6 | 1584c68b58c7f406d9b0e8451beea3e6f8980c56 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-05 | 190 | 127 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.77e-05 | 190 | 127 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | ASK428-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.77e-05 | 190 | 127 | 6 | d649f7e17c4227787465dfc02037f791ff85378b | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.77e-05 | 190 | 127 | 6 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 190 | 127 | 6 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 190 | 127 | 6 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | Control-Lymphoid-NK|Control / Disease state, Lineage and Cell class | 1.77e-05 | 190 | 127 | 6 | f7bd8521a40ac30a64dc439f17e2f6c7d021ef65 | |
| Drug | pyriproxyfen | 1.32e-07 | 23 | 123 | 5 | CID000091753 | |
| Disease | sarcoma (is_marker_for) | 1.55e-04 | 5 | 117 | 2 | DOID:1115 (is_marker_for) | |
| Disease | Recurrent infections | 1.55e-04 | 5 | 117 | 2 | C0239998 | |
| Disease | clubfoot (implicated_via_orthology) | 2.31e-04 | 6 | 117 | 2 | DOID:11836 (implicated_via_orthology) | |
| Disease | coronary artery disease | FNDC3B SEMA3C WIPI1 MAP1B LAMC1 TUB SVEP1 ZNF77 GDPD5 SCUBE1 THADA DENND1B NLRP4 ADGRL3 | 2.77e-04 | 1194 | 117 | 14 | EFO_0001645 |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.94e-04 | 80 | 117 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.58e-04 | 152 | 117 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | myocardial infarction | 5.06e-04 | 350 | 117 | 7 | EFO_0000612 | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 5.51e-04 | 9 | 117 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | cerebral palsy (implicated_via_orthology) | 6.87e-04 | 10 | 117 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | glucose measurement | 8.20e-04 | 380 | 117 | 7 | EFO_0004468 | |
| Disease | Ankylosing spondylitis | 8.38e-04 | 11 | 117 | 2 | C0038013 | |
| Disease | serum ST2 measurement | 8.38e-04 | 11 | 117 | 2 | EFO_0005416 | |
| Disease | Myopia | 8.85e-04 | 385 | 117 | 7 | HP_0000545 | |
| Disease | Secondary Open Angle Glaucoma | 1.00e-03 | 12 | 117 | 2 | C0271148 | |
| Disease | Glaucoma, Open-Angle | 1.00e-03 | 12 | 117 | 2 | C0017612 | |
| Disease | response to fenofibrate | 1.04e-03 | 50 | 117 | 3 | GO_1901557 | |
| Disease | Glaucoma, Primary Open Angle | 1.18e-03 | 13 | 117 | 2 | C0339573 | |
| Disease | sugar consumption measurement | 1.35e-03 | 120 | 117 | 4 | EFO_0010158 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 1.58e-03 | 15 | 117 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | obesity (implicated_via_orthology) | 1.70e-03 | 215 | 117 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Cannabis use | 1.80e-03 | 16 | 117 | 2 | EFO_0007585 | |
| Disease | rhinitis | 2.04e-03 | 17 | 117 | 2 | EFO_0008521 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 2.04e-03 | 17 | 117 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 2.04e-03 | 17 | 117 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 2.04e-03 | 17 | 117 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 2.04e-03 | 17 | 117 | 2 | C0751780 | |
| Disease | May-White Syndrome | 2.04e-03 | 17 | 117 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 2.04e-03 | 17 | 117 | 2 | C0751781 | |
| Disease | glucuronate measurement | 2.29e-03 | 18 | 117 | 2 | EFO_0010486 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 2.29e-03 | 18 | 117 | 2 | C0751779 | |
| Disease | obstructive sleep apnea | 2.32e-03 | 66 | 117 | 3 | EFO_0003918 | |
| Disease | bipolar I disorder | 2.44e-03 | 141 | 117 | 4 | EFO_0009963 | |
| Disease | cortical surface area change measurement, age at assessment | 2.55e-03 | 19 | 117 | 2 | EFO_0008007, EFO_0021503 | |
| Disease | pentachlorophenol measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 3.09e-03 | 73 | 117 | 3 | EFO_0008360 | |
| Disease | ST2 protein measurement | 3.12e-03 | 21 | 117 | 2 | EFO_0010599 | |
| Disease | electroencephalogram measurement | 3.21e-03 | 74 | 117 | 3 | EFO_0004357 | |
| Disease | DDT metabolite measurement | 3.21e-03 | 74 | 117 | 3 | EFO_0007886 | |
| Disease | diffuse plaque measurement | 3.27e-03 | 758 | 117 | 9 | EFO_0010699 | |
| Disease | response to alcohol | 3.33e-03 | 75 | 117 | 3 | EFO_0005526 | |
| Disease | nucleus accumbens volume | 3.42e-03 | 22 | 117 | 2 | EFO_0006931 | |
| Disease | PR interval | 3.65e-03 | 495 | 117 | 7 | EFO_0004462 | |
| Disease | chronic widespread pain | 3.73e-03 | 23 | 117 | 2 | EFO_0010099 | |
| Disease | Depression, Bipolar | 3.86e-03 | 79 | 117 | 3 | C0005587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVTLCSNGVLTYYSS | 281 | Q96P64 | |
| TTTQASYAAQSAYGT | 106 | Q01844 | |
| YASSCNSGTSYNSIS | 1411 | P53355 | |
| SASCTYEGENTVLYL | 431 | Q99424 | |
| TYTCQAITEVNVYGS | 111 | P09564 | |
| SVGTSYSVYDSSAVQ | 71 | Q6ZQR2 | |
| SLFLDSYTEYCTSIT | 776 | Q96Q42 | |
| SYSIASGEYLSNCVQ | 1206 | Q9HAR2 | |
| GSVLCTYTVNETYTT | 251 | P58335 | |
| YASQSSSEGSTQTYA | 731 | Q8TC27 | |
| CETTLANVGYTATYD | 296 | Q5VUD6 | |
| STSTGTILNCYTCAY | 181 | P26436 | |
| STYSDTSAQPTCDYG | 16 | Q9ULX6 | |
| SSTSSYSGYEGCAVL | 266 | Q9H714 | |
| YQSTSETVSITYGTG | 126 | P0DJD9 | |
| TQTSADAIYDCSSLY | 121 | O43827 | |
| EYFEINTSTGCTSFT | 546 | Q7Z6G8 | |
| LAYCTGSVASYELTQ | 11 | P01715 | |
| TDGYTTYINASTCTV | 261 | Q15777 | |
| QGTYVCDYTQSDTVS | 216 | O95256 | |
| GDLSYESSVRCYTQS | 2941 | Q86XX4 | |
| TTRTPDTSTYCYETA | 2031 | P46821 | |
| TPQASTYSYETSDLC | 2051 | P46821 | |
| RNTVYSSSGVCVLYE | 346 | Q99435 | |
| TYSSLLRYTCGSSVE | 486 | Q9NPP4 | |
| ISTDTSGYYICTSSN | 201 | Q99795 | |
| TVYDNCASVSSPYES | 411 | Q9UQF2 | |
| SATGLTADCSYQSYF | 611 | Q5VTL7 | |
| DIDAYTTCLYASGTT | 421 | Q92485 | |
| TVQYISSFYASCLSG | 1441 | Q14C86 | |
| SPGRVYEYTSCTTFS | 356 | Q9UK99 | |
| CSCDGYTNSIYTISI | 321 | Q92824 | |
| CSSTLATTYSSGESY | 351 | Q92824 | |
| SCDGYTNSIYTISVS | 356 | P29122 | |
| YLEECASTLATTYSS | 381 | P29122 | |
| ISFSLTTENSGNYYC | 341 | Q96RD9 | |
| SVTLTCTLSSGYSNY | 36 | A0A0B4J1Y8 | |
| SCVSLGETAASYYGS | 296 | Q13370 | |
| IICGTLYTVSSYTSA | 431 | Q99972 | |
| FSCTDGYVLVYSTDS | 76 | Q9NYR9 | |
| ASTYSIDSVSFSYNT | 106 | P13473 | |
| CSDNSYDTYANSTAT | 571 | Q8WTR4 | |
| LALTCQSTTSVYSSF | 361 | Q96MN2 | |
| EYVSSLSSSVRNTCY | 1556 | A7KAX9 | |
| LSSVTAADTAVYYCA | 101 | P01825 | |
| SYDCTLLAYAESTGT | 141 | A2RRP1 | |
| SVSVFLYYCSADSSA | 681 | Q8NBF2 | |
| YQSTSETVSITYGTG | 126 | P0DJD8 | |
| TGTLSQSYQYEVCLT | 741 | Q9Y5E5 | |
| SYVFSVSYCSSNIIN | 161 | Q8NGP2 | |
| CTQSYSVDSNLLSDY | 361 | Q9Y236 | |
| SYTSQSSTEYYCVTP | 731 | Q9Y2L6 | |
| TCSLNEFTITGSTYA | 376 | P16615 | |
| LDDSCSGSVTYSYSA | 331 | P46100 | |
| RDTPTSCTVDYSTVY | 176 | P40189 | |
| SLANVSYGSIVTYTC | 291 | P20023 | |
| SSIYKSSCTTVYNGY | 211 | Q53EP0 | |
| NASSEYSGTYSCTVR | 201 | P78310 | |
| SSVRYEDTGAYTCIA | 401 | Q6MZW2 | |
| VTLLTGTYYECAASE | 121 | Q5JW98 | |
| SDCLVNTSQISYTIY | 186 | P28221 | |
| NTSQISYTIYSTCGA | 191 | P28221 | |
| YVTLCSNGVLTYYSS | 281 | Q5VUJ5 | |
| IYNITRSDAGSYTCI | 466 | Q9UQ52 | |
| TVYDGYSKHASTTSC | 71 | P0DP58 | |
| SSVCTNAVGYSVYSI | 501 | P11047 | |
| AYTTTAINGTDFCTS | 496 | Q8N4M1 | |
| TGSKEVVCYSYTSTT | 136 | Q7Z589 | |
| SADSSYLQVSSGCYK | 1831 | Q05BV3 | |
| TSSYASQQSKVSGYS | 206 | Q5T8I3 | |
| GEICVSSSATGTAYY | 746 | Q14689 | |
| NEEDYGTCSSSVQYT | 471 | Q6P3S1 | |
| ASPTSITTYETCQTY | 861 | Q8IWY4 | |
| YTCYAANTEGSLNAS | 551 | Q7Z5N4 | |
| VSEVSSTCYNTADIY | 1656 | Q9NZJ4 | |
| ETVPYSVCVSSDYSI | 456 | Q96BR1 | |
| TTFYCNCSDTSYTGA | 566 | Q8WYK1 | |
| SYTGATCHNSIYEQS | 576 | Q8WYK1 | |
| YQSTSETVSITYGTG | 126 | P0DJD7 | |
| SYSNAGEYSTCFTEL | 916 | Q9Y6K5 | |
| CTEEYSTGYTTNSKI | 206 | Q9Y2I2 | |
| STVFSYSSALNLCYA | 611 | O60391 | |
| YSVYRDTCNSSLASL | 271 | P78337 | |
| TGSASFYDCYTSQSE | 56 | A2RUB1 | |
| YTNYSFTLTACTSAG | 3651 | O75445 | |
| CTYINSAVTTSFVGV | 246 | Q5M8T2 | |
| SSVVSDASSAVYYCN | 396 | Q9H6I2 | |
| YSTVLCSYYNSALTT | 256 | Q76EJ3 | |
| CSYYNSALTTAVVGA | 261 | Q76EJ3 | |
| LSTSTKPYDCVTASY | 836 | Q6YHU6 | |
| TTSSSVFKGSAVCVY | 326 | Q99985 | |
| PEYGTYSLCSSQSSS | 161 | Q96CG3 | |
| QSYNCPYSTTTSESS | 16 | A6NCL1 | |
| TASTSYYEAAGTATQ | 326 | P22670 | |
| NVTSTEVYGAFTCSI | 86 | Q6IA17 | |
| FVACAYSGTLSTVSS | 341 | Q8N695 | |
| TFTLISGQCYVTTYE | 81 | Q96H78 | |
| YATVLCTQYNSALTT | 271 | Q9NTN3 | |
| ITYSCRSGYVIQGSS | 3086 | Q4LDE5 | |
| EDSGTYVCTTRNASY | 101 | P27930 | |
| YTVGSYDSFDTSSDC | 606 | Q9UPX8 | |
| SGTTVIYTCEFISAY | 441 | Q8IZF2 | |
| DSSTSASEAYGKSYC | 791 | Q96JN2 | |
| ASEAYGKSYCTTSNS | 796 | Q96JN2 | |
| QYTDAGEYICTASNT | 386 | P13591 | |
| TSSKTVTLFEQYCSG | 506 | Q96JG6 | |
| YSESLLCSNLESATY | 216 | Q15785 | |
| PYADTQNSYGCATST | 296 | Q92574 | |
| QNSYGCATSTPYSTS | 301 | Q92574 | |
| ASLDCYIYVRTSGSS | 41 | Q15935 | |
| YQVLGSSSKTYTCLA | 66 | Q19AV6 | |
| GCVYLYGADTTTATT | 31 | Q6ZVD8 | |
| DYSSTIGSDKGCSQY | 236 | Q7RTY8 | |
| TSCTSSTSSLSNYLY | 216 | Q6ZQN7 | |
| TSCVTFSYDGNVLAS | 381 | Q9NW82 | |
| SYSSYKTCVSSLCVN | 106 | A1A519 | |
| SCSVVGAISSYYVQR | 251 | O75191 | |
| QGFLSSEYTRSYVTC | 271 | Q86WB7 | |
| SEYTRSYVTCTLGIQ | 276 | Q86WB7 | |
| TDVYASYSSVCGAAV | 76 | Q6UXI7 | |
| AALTLNCTYQSSYST | 36 | A0A075B6X5 | |
| VTCGDLSSYDSDRSY | 236 | Q9UET6 | |
| DVCDYTSTTYVGVRN | 761 | Q8TCN5 | |
| TLGSAVAYCTYSLTR | 496 | Q7RTT9 | |
| QYGTTQTLTCTVYAI | 436 | P35968 | |
| SNVDSSYLESLYQSC | 631 | Q7Z2W4 | |
| CLTSVSEYISSDGSY | 146 | P17014 | |
| GTYCYTSSSLSHILQ | 236 | Q5SVZ6 | |
| YSESGVYSQESLTSS | 1021 | Q9Y4F4 | |
| GTEICNYSYSSNILS | 91 | Q5MNZ9 | |
| AELTCTYSTSVGDSF | 41 | Q96IQ7 | |
| VESYLSSSGSTSYQV | 71 | P50607 | |
| YSSTTSDCETDGYLS | 576 | Q96J92 | |
| VCNEYGTTFSQSTYL | 266 | Q8WTR7 | |
| YCSGVESAISSLDYI | 281 | Q9UKW4 | |
| SISQTSVYSEYCSTE | 191 | Q12918 | |
| ISFCSQTTSYVAESS | 106 | Q9P206 | |
| KCSSTLATSYSSGDY | 346 | P29120 |